Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Disease 1

Interventions

pembrolizumab 257 Cyclophosphamide 241 Specimen Handling 198 fludarabine 173 Magnetic Resonance Spectroscopy 173 Biopsy 147 Nivolumab 120 Carboplatin 97 Radiotherapy 92 Paclitaxel 85 venetoclax 82 Cisplatin 80 Gemcitabine 79 fludarabine phosphate 78 Injections 68 Ipilimumab 64 Dexamethasone 62 atezolizumab 59 Bevacizumab 58 Cetuximab 57 Radiation 55 Fluorouracil 55 Azacitidine 55 durvalumab 54 Radiosurgery 52 Temozolomide 47 Rituximab 44 Oxaliplatin 44 Docetaxel 44 Irinotecan 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostatectomy × 1 year × Clear all

NCT07054346 2026-04-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡